Biogen shares fall after Alzheimer’s drug approval. Here’s what the pros are saying
Pros on CNBC discussed Biogen after the Food and Drug Administration approved its Alzheimer's drug.
Source link
Pros on CNBC discussed Biogen after the Food and Drug Administration approved its Alzheimer's drug.
Source link